Evaluation of the effect of LEI's Yinzhan ginger moxibustion combined with Buhuo Shengtu therapy on ulcerative colitis in the remission stage

XU Bao-cai; CHEN Wei

doi:10.16766/j.cnki.issn.1674-4152.002469

Volume 20 Issue 5

May 2022

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Chinese Journal of General Practice > 2022 > 20(5): 844-847

XU Bao-cai, CHEN Wei. Evaluation of the effect of LEI's Yinzhan ginger moxibustion combined with Buhuo Shengtu therapy on ulcerative colitis in the remission stage[J]. Chinese Journal of General Practice, 2022, 20(5): 844-847. doi: 10.16766/j.cnki.issn.1674-4152.002469

Citation:

XU Bao-cai, CHEN Wei. Evaluation of the effect of LEI's Yinzhan ginger moxibustion combined with Buhuo Shengtu therapy on ulcerative colitis in the remission stage[J]. Chinese Journal of General Practice, 2022, 20(5): 844-847. doi: 10.16766/j.cnki.issn.1674-4152.002469

Citation:

PDF( 463 KB)

Evaluation of the effect of LEI's Yinzhan ginger moxibustion combined with Buhuo Shengtu therapy on ulcerative colitis in the remission stage

doi: 10.16766/j.cnki.issn.1674-4152.002469

XU Bao-cai
, CHEN Wei^,

Department of Gastroenterology, Quzhou Hospital of Traditional Chinese Medicine, Quzhou, Zhejiang 324002, China

Funds:

国中医药人教函〔2019〕36号

2018ZA129

2020ZB289

2021ZB324

2015C33274

Received Date: 2021-09-21
Available Online: 2022-09-05

Abstract

Abstract

Objective To evaluate the effect and possible mechanism of LEI's Yinzhan ginger-padded moxibustion combined with Buhuo Shengtu therapy in the treatment of ulcerative colitis (UC) in the remission stage. Methods From January 2017 to June 2020, 73 UC patients in the Department of Gastroenterology, Department of Anus and Intestine of Quzhou Hospital of Traditional Chinese Medicine were randomly divided into two groups according to random number table method. The observation group(n=36) was treated with LEI's Yinzhan ginger-padded moxibustion combined with Buhuo Shengtu therapy, whereas the control group(n=37) was treated with mesalazine. The course of treatment was 4 weeks. The intervention effect and mechanism of the two groups were evaluated. Results After treatment, the efficacy of the observation group was better than that of the control group (Z=2.352, P=0.019). The symptom score of the observation group was lower than that of the control group [(26.04±5.37) scores vs. (32.23±6.45) scores, P < 0.05]. The Mayo score in the observation group was lower than that in the control group [(5.32±1.07) scores vs. (6.75±1.56) scores, P < 0.05]. The levels of serum inflammatory factors (CRP, TNF-α and IL-17) were lower in the observation group than in the control group (all P < 0.05). The levels of NK, CD4⁺ and CD4⁺/CD8⁺ were higher in the observation group than in the control group (all P < 0.05). The IgG and IgM values were significantly lower in the observation group than those in the control group (all P < 0.05). Conclusion LEI's Yinzhan ginger-padded moxibustion combined with Buhuo Shengtu therapy has a definite effect on the treatment of UC in the remission stage, and its mechanism may be related to the regulation of intestinal inflammation and immune function.
- Ulcerative colitis,
- Yinzhan ginger-padded moxibustion,
- Yang deficiency of the spleen and kidney,
- LEI's Medicine

FullText(HTML)

References(16)

References

[1]	程慧, 冯晓莹, 徐华. 炎症性肠病242例临床分析[J]. 中国医科大学学报, 2017, 46(11): 1039-1041. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYK201711018.htm CHENG H, FENG X Y, XU H. Clinical analysis of 242 inflammatory bowel disease cases[J]. Journal of China Medical University, 2017, 46(11): 1039-1041. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYK201711018.htm
[2]	田洁, 王亮, 徐宁. 美沙拉嗪、枯草杆菌二联活菌肠溶胶囊联合用于轻、中度溃疡性结肠炎患者的疗效观察[J]. 实用药物与临床, 2019, 23(3): 296-299. https://www.cnki.com.cn/Article/CJFDTOTAL-LYLC201903021.htm TIAN J, WANG L, XU N. Efficacy of mesalazine combined with Bacillus subtilis enteric-coated capsules in patients with mild to moderate ulcerative colitis[J]. Drugs for use and clinical practice, 2019, 23(3): 296-299. https://www.cnki.com.cn/Article/CJFDTOTAL-LYLC201903021.htm
[3]	毕文静, 柳越冬. 中医治疗慢性非特异性溃疡性结肠炎的研究近况[J]. 辽宁中医杂志, 2017, 44(2): 422-425. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY201702068.htm BI W J, LIU Y D. Recent advances in the study of traditional Chinese medicine in the treatment of chronic non-specific ulcerative colitis[J]. Liaoning J Tradit Chin Med, 2017, 44(2): 422-425. https://www.cnki.com.cn/Article/CJFDTOTAL-LNZY201702068.htm
[4]	邱根祥, 许宝才, 方昉, 等. 衢州雷氏医学源流与学术特色初探[J]. 浙江中医杂志, 2017, 52(11): 781-783. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJZZ201711004.htm QIU G Y, XU B C, FANG F, et al. The origin and academic characteristics of Lehrer' s medicine in Quzhou[J]. Zhejiang Journal of Traditional Chinese medicine, 2017, 52(11): 781-783. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJZZ201711004.htm
[5]	中华医学会消化学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见(2018年·北京)[J]. 中国实用内科杂志, 2018, 38(9): 796-813. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201809007.htm Inflammatory bowel disease group, digestive society, Chinese Medical Association. Consensus on inflammatory bowel disease diagnosis and treatment (Beijing, 2018)[J]. Chinese Journal of Practical Internal Medicine, 2018, 38(9): 796-813. https://www.cnki.com.cn/Article/CJFDTOTAL-SYNK201809007.htm
[6]	中国中西医结合学会消化系统疾病专业委员会. 溃疡性结肠炎中西医结合诊疗共识意见[J]. 中国中西医结合消化杂志, 2018, 26(2): 105-120. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXPW201802001.htm The gastrointestinal disease committee of the Chinese Society of Integrated Traditional Chinese and Western medicine. A ulcerative colitis consensus on the diagnosis and treatment of integrated Chinese and Western medicine[J]. 中国中西医结合消化杂志, 2018, 26(2): 105-120. https://www.cnki.com.cn/Article/CJFDTOTAL-ZXPW201802001.htm
[7]	WANG X R, ZHU Y G, ZHANG M L, et al. The shifted balance beteen circulating follicular regulatory T cells and follicular helper T cells in patients with ulcerative colitis[J]. Clin Sci, 2017, 131(24): 2933-2945. doi: 10.1042/CS20171258
[8]	张冰, 谢晶日, 孙涛. 中药内服与灌肠治疗活动期溃疡性结肠炎的临床疗效[J]. 中华全科医学, 2019, 17(2): 284-287. doi: 10.16766/j.cnki.issn.1674-4152.000662 ZHANG B, XIE J R, SUN T. Clinical efficacy of oral Chinese medicine and enema in the treatment of active ulcerative colitis[J]. Chinese general practice, 2019, 17(2): 284-287. doi: 10.16766/j.cnki.issn.1674-4152.000662
[9]	丁栋, 李佳妮, 齐冉, 等. 溃疡性结肠炎的研宄进展[J]. 药学研究, 2017, 36(7): 404-408. DING D, LI J N, QI R, et al. Progress in ulcerative colitis research[J]. Pharmaceutical Research, 2017, 36(7): 404-408.
[10]	翁湘涛, 胡月, 廖柳, 等. 参苓白术散加减对比西药治疗溃疡性结肠炎的疗效和安全性meta分析[J]. 中国实验方剂学杂志, 2017, 23(10): 205-210. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201710034.htm WEN X T, HU Y, LIAO L, et al. Meta-analysis of the efficacy and safety of Shenlingbaizhu powder in the treatment of ulcerative colitis disease[J]. Chinese Journal of experimental prescription, 2017, 23(10): 205-210. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX201710034.htm
[11]	肖迅, 张燕. 中药有效成分/有效部位治疗溃疡性结肠炎的研究进展[J]. 中药药理与临床, 2017, 33(3): 219-223. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYL201703067.htm XIAO X, ZHANG Y. Research progress of effective components and active parts of Chinese herbal medicine in the treatment of ulcerative colitis[J]. Pharmacology and clinic of Chinese materia medica, 2017, 33(3): 219-223. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYYL201703067.htm
[12]	许宝才, 陈刚, 吴世泉. 陈伟主任医师论治脾胃病的学术经验[J]. 中国中医急症, 2018, 27(10): 1838-1841. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJZ201810045.htm XU B C, CHEN G, WU S Q. Professor Chen Wei' s academic experience in treating spleen and stomach diseases[J]. Chinese traditional medicine emergency, 2018, 27(10): 1838-1841. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJZ201810045.htm
[13]	李宛蓉, 李博, 赵天易, 等. 古代灸疗医案中的灸法应用规律研究[J]. 中华中医药杂志, 2019, 34(3): 1181-1183. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201903088.htm LI W R, LI B, ZHAO T Y, et al. Study on the law of application of Moxibustion in ancient medical records[J]. Chin J Tradit Chin Med Pharm, 2019, 34(3): 1181-1183. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201903088.htm
[14]	许宝才, 邱根祥, 陈伟, 等. 雷氏补火生土法配合脐疗治疗腹泻型肠易激综合征临床研究[J]. 新中医, 2018, 50(6): 195-198. https://www.cnki.com.cn/Article/CJFDTOTAL-REND201806058.htm XU B C, QIU G Y, CHEN Q, et al. Clinical study on the treatment of diarrhea-predominant irritable bowel syndrome (IBS) with Lei' s method of reinforcing fire and generating Earth combined with navel therapy[J]. New Chinese medicine, 2018, 50(6): 195-198. https://www.cnki.com.cn/Article/CJFDTOTAL-REND201806058.htm
[15]	SHEN Z H, ZHU C X, QUAN Y S, et al. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation[J]. World J Gastroenterol, 2018, 24(1): 5-14. doi: 10.3748/wjg.v24.i1.5
[16]	甄建华, 黄光瑞. 溃疡性结肠炎病因和发病机制的现代医学研究进展[J]. 世界华人消化杂志, 2019, 27(4): 245-251. https://www.cnki.com.cn/Article/CJFDTOTAL-XXHB201904006.htm ZHEN J H, HUANG G R. Advances in modern medical research on the etiology and pathogenesis of ulcerative colitis[J]. World Journal of Chinese digestion, 2019, 27(4): 245-251. https://www.cnki.com.cn/Article/CJFDTOTAL-XXHB201904006.htm

Relative Articles

[1]	CUI Xiaoting, LU Jie, NIU Haoshu, ZHAO Cuijuan. Changes in ERK1/2 signaling pathway in the progression of ulcerative colitis and its association with intestinal opportunistic infections[J]. Chinese Journal of General Practice, 2024, 22(10): 1636-1639. doi: 10.16766/j.cnki.issn.1674-4152.003700
[2]	XU Boyang, YANG Wendi, LI Wei, JIA Zhichun, XU Wei, WANG Jiawan. Comparison and analysis of traditional Chinese medicine and Western medicine in the treatment of ulcerative colitis[J]. Chinese Journal of General Practice, 2024, 22(10): 1640-1644. doi: 10.16766/j.cnki.issn.1674-4152.003701
[3]	SHU Yuping, YU Danqi, RONG Yue, TAO Hongwu, LIU Yuedong. Causal relationship between ulcerative colitis and bronchiectasis based on mendelian randomization[J]. Chinese Journal of General Practice, 2023, 21(6): 924-926. doi: 10.16766/j.cnki.issn.1674-4152.003016
[4]	HUANG Hong, XU Bao-cai. Study on the magnetic resonance colonography combined with fecal calprotectin in the diagnosis of ulcerative colitis[J]. Chinese Journal of General Practice, 2022, 20(12): 2101-2104. doi: 10.16766/j.cnki.issn.1674-4152.002779
[5]	XU Feng, XU Lin-xia, LIU Wei, WANG Ke-ke, CHEN Cai-feng, Xie Li, KE Xi-quan. The molecular mechanism of sinomenine hydrochloride treat ulcerative colitis through Hedgehog signalling pathway in mice[J]. Chinese Journal of General Practice, 2022, 20(10): 1654-1657. doi: 10.16766/j.cnki.issn.1674-4152.002671
[6]	ZHANG Wen-ting, GU Lin, KE Xi-quan, WANG Qi-zhi, WANG Qiang-wu, WANG Jian-chao, LI Da-peng. Expressions of TLR9 and STAT3 and their correlation with IL-10 in patients with ulcerative colitis[J]. Chinese Journal of General Practice, 2021, 19(6): 921-924. doi: 10.16766/j.cnki.issn.1674-4152.001950
[7]	ZHANG Bing, XIE Jing-ri, SUN Tao. Effects of Changyuning Decoction on protein expression of claudin-1, ZO-1 and occludin in colonic tissue of rats with ulcerative colitis[J]. Chinese Journal of General Practice, 2021, 19(9): 1447-1450, 1577. doi: 10.16766/j.cnki.issn.1674-4152.002082
[8]	JIANG Hai-yan, WANG Yin-xue, WANG Jian-yun, LIU Da-min, SUN Hui-yi, ZHANG Wen. Clinical study of Jiedu Huoxue Decoction enema combined with oral Chinese medicine in patients with ulcerative colitis[J]. Chinese Journal of General Practice, 2021, 19(11): 1925-1928,1955. doi: 10.16766/j.cnki.issn.1674-4152.002202
[9]	WANG Song, LIU Liu, ZHANG Kai-guang. Clinical value of monocytes and monocyte-to-lymphocyte ratio in determining the severity of ulcerative colitis[J]. Chinese Journal of General Practice, 2020, 18(6): 895-898,1065. doi: 10.16766/j.cnki.issn.1674-4152.001386
[10]	YU Ye-ming, GU Lin, YAN Shan-jun, . Relationship between JAM-1 and STAT3 signaling pathway in patients with ulcerative colitis[J]. Chinese Journal of General Practice, 2019, 17(3): 370-373. doi: 10.16766/j.cnki.issn.1674-4152.000684
[11]	LIU Hai-yan, CHEN Jun-xian, XU Ping-zhen. Clinical significance of urine NGAL and MMP-9 in the patients of ulcerative colitis[J]. Chinese Journal of General Practice, 2019, 17(5): 776-778. doi: 10.16766/j.cnki.issn.1674-4152.000789
[12]	ZHANG Bing, XIE Jing-ri, SUN Tao. Clinical observation on treatment of active ulcerative colitis with Chinese herbal decoction for oral taking and enema[J]. Chinese Journal of General Practice, 2019, 17(2): 284-287. doi: 10.16766/j.cnki.issn.1674-4152.000662
[13]	XU Zai-ling, SHI Hua, LIU Jun-wei, ZHAO Zhong-wei, PEI Li-hong. Effect and mechanism of Omega-3 polyunsaturated fatty acids in the treatment of ulcerative colitis[J]. Chinese Journal of General Practice, 2018, 16(4): 561-563,596. doi: 10.16766/j.cnki.issn.1674-4152.000155
[14]	LI Si, SHEN Yan, ZHONG Ji-hong, XU Lei, WANG Zhang-liu, ZHENG Hua-jun, ZHANG Bing. Effects of Berberine extracted from Chinese Goldthread Rhizome on the intestinal mucosal mechanical barrier in mice with ulcerative colitis[J]. Chinese Journal of General Practice, 2018, 16(9): 1419-1423. doi: 10.16766/j.cnki.issn.1674-4152.000388
[15]	YU Hong-fen. The changes of inflammatory factors,oxidative stress,bone mineral density and bone metabolic indices in children with ulcerative colitis[J]. Chinese Journal of General Practice, 2017, 15(12): 2106-2108. doi: 10.16766/j.cnki.issn.1674-4152.2017.12.031
[16]	CHEN Yuan-e, GUO Xu-ri, GAO Cong-ying, JIANG Yi. Effect of psychological intervention on serotonin and anxiety scores in patients with ulcerative colitis[J]. Chinese Journal of General Practice, 2017, 15(12): 2112-2114. doi: 10.16766/j.cnki.issn.1674-4152.2017.12.033
[17]	DU Li-yun, ZHU Qin, LIN Ling-ping, NI Li-ping. Effects of synergistic nursing model on IL-23,IL-17 inflammatory factors and psychological and physical condition in patients with ulcerative colitis[J]. Chinese Journal of General Practice, 2017, 15(4): 700-703. doi: 10.16766/j.cnki.issn.1674-4152.2017.04.047
[18]	CAO Ming-wei, WU Dan-dan, JI Meng-yao, MA Jing-jing, DONG Wei-guo. The relationship between the neutrophil-lymphocyte ratio and endoscopic activity in ulcerative colitis[J]. Chinese Journal of General Practice, 2017, 15(3): 390-392,536. doi: 10.16766/j.cnki.issn.1674-4152.2017.03.008
[19]	ZHENG Bo, MIN Xiao-yan, WANG Jian-zhang, PEI Ji-hua, XU Chang-long, JIANG Yi. Associations of ulcerative colitis with Bsm Ⅰ,Apa Ⅰ and Taq Ⅰ polymorphisms in vitamin D receptor gene[J]. Chinese Journal of General Practice, 2016, 14(3): 368-370. doi: 10.16766/j.cnki.issn.1674-4152.2016.03.009
[20]	YIN Li-min, ZHANG Zhong-chen, LIU Jin-lin. Curative effect of sertraline hydrochloride tablets on depression in patients with ulcerative colitis[J]. Chinese Journal of General Practice, 2016, 14(5): 810-813. doi: 10.16766/j.cnki.issn.1674-4152.2016.05.039

Supplements(0)

Cited By

Cited by

Periodical cited type(6)

1.	王兴家，石鹏岩，屠庆祝. 中医治疗缓解期溃疡性结肠炎的研究进展. 中国民间疗法. 2024(08): 117-119 .
2.	许博洋，杨雯迪，李伟，贾志春，徐伟，王嘉婉. 中西医治疗溃疡性结肠炎的比较与分析. 中华全科医学. 2024(10): 1640-1644+1713 . 本站查看
3.	杨梅，童景飞，高莺，于雪瑶. 低FODMAP饮食指导的延续性护理对溃疡性结肠炎患者营养状况和肠道菌群的影响. 中华全科医学. 2024(11): 1990-1994 . 本站查看
4.	张嘉程，朱文静，王晓宇，刘高新丽，范顺，白雪，安成飞，宁静，刘川，王金贵. 艾灸治疗溃疡性结肠炎的研究现状与思考. 世界中医药. 2024(19): 3039-3044 .
5.	舒郁平，余丹琪，荣越，陶弘武，柳越冬. 基于孟德尔随机化法的溃疡性结肠炎与支气管扩张症的因果关系研究. 中华全科医学. 2023(06): 924-926+1043 . 本站查看
6.	蒋叶，施建丰，贺妍妍，蔡婷婷. 覆盆子改善溃疡性结肠炎小鼠模型的作用研究. 药物生物技术. 2022(06): 580-584 .

Other cited types(3)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Tables(6)

Get Citation

PDF

XML

Article Metrics

Article views (258) PDF downloads(3)

Evaluation of the effect of LEI's Yinzhan ginger moxibustion combined with Buhuo Shengtu therapy on ulcerative colitis in the remission stage

doi: 10.16766/j.cnki.issn.1674-4152.002469